Kardioaktiv 0.5g 60 pcs taurine tab

Description

Composition
Active substance:
1 tablet contains: Taurine – 500 mg.
Excipients:
Povidone – 57.0 mg Microcrystalline cellulose – 18.0 mg Croscarmellose sodium – 17.2 mg Calcium stearate – 4.8 mg Colloidal silicon dioxide – 3.0 mg.
Description:
Tablets white or almost white, round, Valium with Valium and a facet.
Product form:
Tablets of 500 mg. 20 tablets in blisters of PVC film and flexible packaging made on the basis of aluminum foil. 2 or 3 blisters together with instructions for use placed in a pile of cardboard.
Contraindications
Contraindications
Severe heart failure decompensation.
Hypersensitivity to the drug.
KardioAktiv Taurine is not recommended for use in children under the age of 18 years due to lack of efficacy and safety data.
Precautions for the use of
Be wary of patients with severe renal impairment, while the use of cardiac glycosides, blockers “slow” calcium channel (BCCI).
Dosage
500 mg
Indications
The drug is used in the treatment of: cardiovascular failure of various etiologies; intoxication caused by taking cardiac glycosides; type 1 diabetes; type 2 diabetes, including those with moderate hypercholesterolemia.
Interaction with other drugs
KardioAktiv Taurine may be used with other drugs.
Taurine enhances the inotropic effect of cardiac glycosides.
Overdose
Data on overdose are not available.
pharmachologic effect
Pharmacological group:
Metabolic means.
Pharmacodynamics:
Taurine is a natural product of the sulfur-containing amino acid metabolism: cysteine, cysteamine, methionine. Taurine has osmoregulatory and membrane properties, positively affects the phospholipid composition of cell membranes, normalizes the exchange of calcium and potassium ions in the cells. At taurine identified properties inhibitory neurotransmitter, it has anti-stress effect, can control the release gammaaminomaslyanoy acid (GABA), adrenaline and other hormones prolactin, but also to regulate their answers. By participating in the synthesis of proteins in the respiratory chain of mitochondria, taurine regulates oxidative processes and exhibits antioxidant properties; effect on enzymes such as cytochromes, involved in the metabolism of various xenobiotics.
Taurine improves metabolic processes in the heart, liver and other organs and tissues. In chronic diffuse liver diseases taurine increases blood flow and reduces the severity of cytolysis.
Treatment with KardioAktiv Taurine in cardiovascular disease (CCH) leads to a decrease of stagnation in the small and large circles circulation: reduced intracardiac diastolic pressure, increasing myocardial contractility (maximum speed of contraction and relaxation, contractility index and relaxation time). The drug is moderately reduce blood pressure (BP) in patients with hypertension and has virtually no effect on blood pressure in patients with cardiovascular failure with low blood pressure.
Taurine KardioAktiv reduces side effects arising from overdosage blockers, cardiac glycosides and “slow” calcium channel; decreases hepatotoxicity antifungal agents. Increases efficiency under heavy physical exertion.
In diabetes approximately 2 weeks after receiving the drug KardioAktiv Tuarin decreases in blood glucose concentration. It is also noticed significant reduction of triglyceride concentration, to a lesser extent – cholesterol concentration, reduction in atherogenic plasma lipids. With long-term use of the drug (about 6 months) improvement of microcirculatory blood flow observed eye.
Pharmacokinetics:
After a single oral 500 mg dose KardioAktiv Taurine Taurine active substance after 15-20 minutes it is determined in the blood, reaching a peak after 1.5-2 hours. Fully drug appears in a day.
Pregnancy and breast-feeding
It is not recommended to use the drug KardioAktiv Taurine during pregnancy and breastfeeding due to lack of adequate clinical experience in these patients.
Conditions of supply of pharmacies
Available without prescription.
side effects
Allergic reactions to the drug.
special instructions
When the complex treatment of heart failure, diabetes, cardiac glycoside intoxication taking the drug carried out under the supervision of a physician.
The drug does not affect the performance of potentially hazardous activities that require high concentration and speed of psychotropic reactions (vehicle control, work with moving machinery, the work manager, operator, etc.).
Storage conditions
Store at a temperature not higher than 25 C.
Keep out of the reach of children.
Dosing and Administration
Before using the product, consult a doctor.
In heart failure KardioAktiv Taurine ingest 250-500 mg of (1/2 – 1 tablet), 2 times a day 20 minutes before meal treatment – 30 days. The dose may be increased to 2-3 g (4-6 tablets) per day.
When cardiac glycoside intoxication – not less than 750 mg (1.5 tablets) per day.
In diabetes type 1 – 500 mg (1 tablet), 2 times a day in combination with insulin therapy for 3-6 months.
In type 2 diabetes – 500 mg (1 tablet), 2 times a day in combination with diet or other hypoglycemic agents for oral administration.
In type 2 diabetes, including moderate hypercholesterolemia – 500 mg (1 tablet), 2 times a day.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist